{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:35:41Z","timestamp":1792888541454,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00210-026-05680-4","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T03:01:32Z","timestamp":1784170892000},"page":"21099-21117","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lapatinib mitigates acetic acid-induced ulcerative colitis and hepatic damage in rats"],"prefix":"10.1007","volume":"399","author":[{"given":"Abdullah S.","family":"Al-Resheedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda E.","family":"Kafl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada M.","family":"Suddek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"issue":"34","key":"5680_CR1","doi-asserted-by":"publisher","first-page":"5633","DOI":"10.3748\/wjg.v19.i34.5633","volume":"19","author":"SS Al-Rejaie","year":"2013","unstructured":"Al-Rejaie SS, Abuohashish HM, Al-Enazi MM, Al-Assaf AH, Parmar MY, Ahmed MM (2013) Protective effect of naringenin on acetic acid-induced ulcerative colitis in rats. World J Gastroenterol 19(34):5633\u20135644","journal-title":"World J Gastroenterol"},{"key":"5680_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119433","volume":"276","author":"FEM Ali","year":"2021","unstructured":"Ali FEM, Elfiky MM, Fadda WA, Ali HS, Mahmoud AR, Mohammedsaleh ZM, Abd-Elhamid TH (2021) Regulation of IL-6\/STAT-3\/Wnt axis by nifuroxazide dampens colon ulcer in acetic acid-induced ulcerative colitis model: novel mechanistic insight. Life Sci 276:119433","journal-title":"Life Sci"},{"key":"5680_CR3","doi-asserted-by":"publisher","first-page":"6237","DOI":"10.3748\/wjg.v19.i37.6237","volume":"19","author":"P Ataca","year":"2013","unstructured":"Ataca P, Soyturk M, Karaman M, Unlu M, Sagol O, Dervis Hakim G, Yilmaz O (2013) Nilotinib-mediated mucosal healing in a rat model of colitis. World J Gastroenterol 19:6237\u20136244","journal-title":"World J Gastroenterol"},{"issue":"2","key":"5680_CR4","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1152\/physrev.00040.2012","volume":"94","author":"A Bhattacharyya","year":"2014","unstructured":"Bhattacharyya A, Chattopadhyay R, Mitra S, Crowe SE (2014) Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases. Physiol Rev 94(2):329\u2013354","journal-title":"Physiol Rev"},{"key":"5680_CR5","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.clinre.2015.12.006","volume":"40","author":"G Can","year":"2016","unstructured":"Can G, Ayvaz S, Can H, Karabo\u011fa \u0130, Demirta\u015f S, Ak\u015fit H, Y\u0131lmaz B, Korkmaz U, Kurt M, Karaca T (2016) The efficacy of tyrosine kinase inhibitor dasatinib on colonic mucosal damage in murine model of colitis. Clin Res Hepatol Gastroenterol 40:504\u2013516","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"5680_CR6","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1002\/jcp.23029","volume":"227","author":"R Ciarcia","year":"2012","unstructured":"Ciarcia R, Vitiello MT, Galdiero M, Pacilio C, Iovane V, d\u2019Angelo D, Pagnini D, Caparrotti G, Conti D, Tomei V, Florio S, Giordano A (2012) Imatinib treatment inhibit IL-6, IL-8, NF-KB and AP-1 production and modulate intracellular calcium in CML patients. J Cell Physiol 227:2798\u20132803","journal-title":"J Cell Physiol"},{"key":"5680_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phrs.2013.06.007","volume":"76","author":"M Coskun","year":"2013","unstructured":"Coskun M, Salem M, Pedersen J, Nielsen OH (2013) Involvement of JAK\/STAT signaling in the pathogenesis of inflammatory bowel disease. Pharmacol Res 76:1\u20138","journal-title":"Pharmacol Res"},{"issue":"4","key":"5680_CR8","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.immuni.2019.03.017","volume":"50","author":"M Friedrich","year":"2019","unstructured":"Friedrich M, Pohin M, Powrie F (2019) Cytokine networks in the pathophysiology of inflammatory bowel disease. Immunity 50(4):992\u20131006","journal-title":"Immunity"},{"key":"5680_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/biology14040347","author":"M Garc\u00eda-Dom\u00ednguez","year":"2025","unstructured":"Garc\u00eda-Dom\u00ednguez M (2025) The role of IL-23 in the development of inflammatory diseases. Biology. https:\/\/doi.org\/10.3390\/biology14040347","journal-title":"Biology"},{"key":"5680_CR10","doi-asserted-by":"publisher","first-page":"4810258","DOI":"10.1155\/2017\/4810258","volume":"2017","author":"Q Guan","year":"2017","unstructured":"Guan Q, Zhang J (2017) Recent Advances: The Imbalance of Cytokines in the Pathogenesis of Inflammatory Bowel Disease. Mediators Inflamm 2017:4810258","journal-title":"Mediators Inflamm"},{"issue":"12","key":"5680_CR11","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1097\/MIB.0000000000000180","volume":"20","author":"J Han","year":"2014","unstructured":"Han J, Theiss AL (2014) Stat3: friend or foe in colitis and colitis-associated cancer? Inflamm Bowel Dis 20(12):2405\u20132411","journal-title":"Inflamm Bowel Dis"},{"key":"5680_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12950-020-00246-4","volume":"17","author":"A Kaur","year":"2020","unstructured":"Kaur A, Goggolidou P (2020) Ulcerative colitis: understanding its cellular pathology could provide insights into novel therapies. J Inflamm (Lond) 17:15","journal-title":"J Inflamm (Lond)"},{"issue":"5","key":"5680_CR13","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/ceo.12500","volume":"43","author":"MK Kaya","year":"2015","unstructured":"Kaya MK, Demir T, Bulut H, Akpolat N, Turgut B (2015) Effects of lapatinib and trastuzumab on vascular endothelial growth factor in experimental corneal neovascularization. Clin Exp Ophthalmol 43(5):449\u2013457","journal-title":"Clin Exp Ophthalmol"},{"issue":"1","key":"5680_CR14","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41572-020-0205-x","volume":"6","author":"T Kobayashi","year":"2020","unstructured":"Kobayashi T, Siegmund B, Le Berre C, Wei SC, Ferrante M, Shen B, Bernstein CN, Danese S, Peyrin-Biroulet L, Hibi T (2020) Ulcerative colitis. Nat Rev Dis Primers 6(1):74","journal-title":"Nat Rev Dis Primers"},{"key":"5680_CR15","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/j.biopha.2018.10.187","volume":"109","author":"VL Kumar","year":"2019","unstructured":"Kumar VL, Pandey A, Verma S, Das P (2019) Protection afforded by methanol extract of Calotropis procera latex in experimental model of colitis is mediated through inhibition of oxidative stress and pro-inflammatory signaling. Biomed Pharmacother 109:1602\u20131609","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"5680_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0197668","volume":"13","author":"R Kutsuna","year":"2018","unstructured":"Kutsuna R, Tomida J, Morita Y, Kawamura Y (2018) Paraclostridium bifermentans exacerbates pathosis in a mouse model of ulcerative colitis. PLoS ONE 13(5):e0197668","journal-title":"PLoS ONE"},{"issue":"50","key":"5680_CR17","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000036629","volume":"102","author":"X Liu","year":"2023","unstructured":"Liu X, Huan Y, Wang Y, Huang Y (2023) Ulcerative colitis coexisting with hepatitis C: a rare occurrence. Medicine (Baltimore) 102(50):e36629","journal-title":"Medicine (Baltimore)"},{"key":"5680_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175875","volume":"954","author":"HM Mansour","year":"2023","unstructured":"Mansour HM, Mohamed AF, Khattab MM, El-Khatib AS (2023) Lapatinib ditosylate rescues motor deficits in rotenone-intoxicated rats: potential repurposing of anti-cancer drug as a disease-modifying agent in Parkinson\u2019s disease. Eur J Pharmacol 954:175875","journal-title":"Eur J Pharmacol"},{"key":"5680_CR19","doi-asserted-by":"crossref","unstructured":"Mansouri RA, Ahmed AM, Alshaibi HF, Al-Bazi MM, Banjabi AA, Alsufiani HM, Aloqbi AA, Aboubakr EM (2023) A new cirrhotic animal protocol combining carbon tetrachloride with methotrexate to address limitations of the currently used chemical-induced models. Front Pharmacol 14:2023","DOI":"10.3389\/fphar.2023.1201583"},{"issue":"4","key":"5680_CR20","doi-asserted-by":"publisher","first-page":"5945","DOI":"10.1007\/s11356-021-16092-7","volume":"29","author":"NI Mohamed","year":"2022","unstructured":"Mohamed NI, El-Kashef DH, Suddek GM (2022) Flavocoxid halts both intestinal and extraintestinal alterations in acetic acid-induced colitis in rats. Environ Sci Pollut Res Int 29(4):5945\u20135959","journal-title":"Environ Sci Pollut Res Int"},{"issue":"4","key":"5680_CR21","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1248\/bpb.b26-00003","volume":"49","author":"M Mori","year":"2026","unstructured":"Mori M, Ishii M, Nakagawa R, Morimoto K, Ise K, Nakamura Y, Tomita M (2026) Localized rectal dextran sulfate sodium-induced colitis is associated with small-intestinal shortening and gut-liver axis-related alterations. Biol Pharm Bull 49(4):708\u2013719","journal-title":"Biol Pharm Bull"},{"key":"5680_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.semcancer.2019.05.001","volume":"64","author":"MS Nadeem","year":"2020","unstructured":"Nadeem MS, Kumar V, Al-Abbasi FA, Kamal MA, Anwar F (2020) Risk of colorectal cancer in inflammatory bowel diseases. Semin Cancer Biol 64:51\u201360","journal-title":"Semin Cancer Biol"},{"issue":"33","key":"5680_CR23","doi-asserted-by":"publisher","first-page":"4814","DOI":"10.3748\/wjg.v25.i33.4814","volume":"25","author":"A Nicoletti","year":"2019","unstructured":"Nicoletti A, Ponziani FR, Biolato M, Valenza V, Marrone G, Sganga G, Gasbarrini A, Miele L, Grieco A (2019) Intestinal permeability in the pathogenesis of liver damage: from non-alcoholic fatty liver disease to liver transplantation. World J Gastroenterol 25(33):4814\u20134834","journal-title":"World J Gastroenterol"},{"issue":"4","key":"5680_CR24","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/cld.1046","volume":"17","author":"P Patel","year":"2021","unstructured":"Patel P, Dalal S (2021) Hepatic manifestations of inflammatory bowel disease. Clin Liver Dis (Hoboken) 17(4):292\u2013296","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"5680_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1200111","volume":"14","author":"S Peng","year":"2023","unstructured":"Peng S, Shen L, Yu X, Zhang L, Xu K, Xia Y, Zha L, Wu J, Luo H (2023) The role of Nrf2 in the pathogenesis and treatment of ulcerative colitis. Front Immunol 14:1200111","journal-title":"Front Immunol"},{"key":"5680_CR26","doi-asserted-by":"crossref","unstructured":"Ricart E (2024) Ulcerative colitis. In: Shoenfeld Y, Cervera R, Espinosa G, Gershwin ME (eds) Autoimmune disease diagnosis: systemic and organ-specific diseases. Springer Nature Switzerland, Cham, pp 459\u2013463","DOI":"10.1007\/978-3-031-69895-8_64"},{"key":"5680_CR27","doi-asserted-by":"crossref","unstructured":"Roda G, Chien Ng S, Kotze PG, Argollo M, Panaccione R, Spinelli A, Kaser A, Peyrin-Biroulet L, Danese S (2020) Crohn\u2019s disease. Nat Rev Dis Primers 6(1):22","DOI":"10.1038\/s41572-020-0156-2"},{"issue":"42","key":"5680_CR28","doi-asserted-by":"publisher","first-page":"7327","DOI":"10.3748\/wjg.v19.i42.7327","volume":"19","author":"M Rojas-Feria","year":"2013","unstructured":"Rojas-Feria M, Castro M, Su\u00e1rez E, Ampuero J, Romero-G\u00f3mez M (2013) Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver. World J Gastroenterol 19(42):7327\u20137340","journal-title":"World J Gastroenterol"},{"issue":"7","key":"5680_CR29","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/ncpgasthep0528","volume":"3","author":"RB Sartor","year":"2006","unstructured":"Sartor RB (2006) Mechanisms of disease: pathogenesis of Crohn\u2019s disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 3(7):390\u2013407","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"5680_CR30","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.cytogfr.2014.07.016","volume":"25","author":"L Sedger","year":"2014","unstructured":"Sedger L (2014) From mediators of cell death and inflammation to therapeutic giants\u2014past, present and future\/Sedger LM, McDermott MF. Cytokine Growth Factor Rev 25:453\u2013472","journal-title":"Cytokine Growth Factor Rev"},{"issue":"2","key":"5680_CR31","doi-asserted-by":"publisher","first-page":"113","DOI":"10.25122\/jml-2018-0075","volume":"12","author":"SS Seyedian","year":"2019","unstructured":"Seyedian SS, Nokhostin F, Malamir MD (2019) A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease. J Med Life 12(2):113\u2013122","journal-title":"J Med Life"},{"key":"5680_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.121596","volume":"321","author":"M Shalaby","year":"2023","unstructured":"Shalaby M, Abdelaziz RR, Ghoneim HA, Suddek GM (2023) Imatinib mitigates experimentally-induced ulcerative colitis: possible contribution of NF-kB\/JAK2\/STAT3\/COX2 signaling pathway. Life Sci 321:121596","journal-title":"Life Sci"},{"issue":"2","key":"5680_CR33","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/jnci\/djn436","volume":"101","author":"TE Strecker","year":"2009","unstructured":"Strecker TE, Shen Q, Zhang Y, Hill JL, Li Y, Wang C, Kim H-T, Gilmer TM, Sexton KR, Hilsenbeck SG (2009) Effect of lapatinib on the development of estrogen receptor\u2013negative mammary tumors in mice. J Natl Cancer Inst 101(2):107\u2013113","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"5680_CR34","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1053\/j.gastro.2011.02.016","volume":"140","author":"W Strober","year":"2011","unstructured":"Strober W, Fuss IJ (2011) Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology 140(6):1756\u20131767","journal-title":"Gastroenterology"},{"key":"5680_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107992","volume":"232","author":"S Sui","year":"2022","unstructured":"Sui S, Xu S, Pang D (2022) Emerging role of ferroptosis in breast cancer: new dawn for overcoming tumor progression. Pharmacol Ther 232:107992","journal-title":"Pharmacol Ther"},{"key":"5680_CR36","first-page":"557","volume-title":"Bancroft\u2019s theory and practice of histological techniques","author":"K Suvarna","year":"2019","unstructured":"Suvarna K, Layton C, Bancroft JD (2019) Bancroft\u2019s theory and practice of histological techniques, 9th Edition. Elsevier, p 557","edition":"9th Edition"},{"key":"5680_CR37","doi-asserted-by":"crossref","unstructured":"Tang X, Huang Y, Zhu Y, Xu Y (2025) Immune dysregulation in ulcerative colitis: pathogenic mechanisms and therapeutic strategies of traditional Chinese medicine.\u00a0Front Cell Dev Biol\u00a013:1610435","DOI":"10.3389\/fcell.2025.1610435"},{"issue":"17","key":"5680_CR38","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1089\/ars.2017.7342","volume":"29","author":"C Tonelli","year":"2018","unstructured":"Tonelli C, Chio IIC, Tuveson DA (2018) Transcriptional regulation by Nrf2. Antioxid Redox Signal 29(17):1727\u20131745","journal-title":"Antioxid Redox Signal"},{"issue":"12","key":"5680_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18122772","volume":"18","author":"S Vomund","year":"2017","unstructured":"Vomund S, Sch\u00e4fer A, Parnham MJ, Br\u00fcne B, Von Knethen A (2017) Nrf2, the master regulator of anti-oxidative responses. Int J Mol Sci 18(12):2772","journal-title":"Int J Mol Sci"},{"key":"5680_CR40","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.biopha.2016.11.061","volume":"85","author":"H Wang","year":"2017","unstructured":"Wang H, Gu J, Hou X, Chen J, Yang N, Liu Y, Wang G, Du M, Qiu H, Luo Y, Jiang Z, Feng L (2017) Anti-inflammatory effect of miltirone on inflammatory bowel disease via TLR4\/NF-\u03baB\/IQGAP2 signaling pathway. Biomed Pharmacother 85:531\u2013540","journal-title":"Biomed Pharmacother"},{"key":"5680_CR41","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/jid.2014.383","volume":"135","author":"NL Wu","year":"2015","unstructured":"Wu NL, Huang DY, Tsou HN, Lin YC, Lin WW (2015) Syk mediates IL-17-induced CCL20 expression by targeting Act1-dependent K63-linked ubiquitination of TRAF6. J Invest Dermatol 135:490\u2013498","journal-title":"J Invest Dermatol"},{"issue":"10","key":"5680_CR42","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1093\/ibd\/izz149","volume":"25","author":"D Yao","year":"2019","unstructured":"Yao D, Dong M, Dai C, Wu S (2019) Inflammation and inflammatory cytokine contribute to the initiation and development of ulcerative colitis and its associated cancer. Inflamm Bowel Dis 25(10):1595\u20131602","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"5680_CR43","first-page":"190","volume":"12","author":"C Zhang","year":"2019","unstructured":"Zhang C, Liu J, Yuan C, Ji Q, Chen D, Zhao H, Jiang W, Ma K, Liu L (2019) JAK2\/STAT3 is associated with the inflammatory process in periapical granuloma. Int J Clin Exp Pathol 12(1):190\u2013197","journal-title":"Int J Clin Exp Pathol"},{"key":"5680_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108417","volume":"245","author":"X-N Zhang","year":"2023","unstructured":"Zhang X-N, Gao Y, Zhang X-Y, Guo N-J, Hou W-Q, Wang S-W, Zheng Y-C, Wang N, Liu H-M, Wang B (2023) Detailed curriculum vitae of HER2-targeted therapy. Pharmacol Ther 245:108417","journal-title":"Pharmacol Ther"},{"key":"5680_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115356","volume":"295","author":"Y Zheng","year":"2022","unstructured":"Zheng Y, Liang C, Li Z, Chen J, Chen Z, Jiang Y, Dong Q, Xiao Y, Fu C, Liao W, Yuan X (2022) Study on the mechanism of huangqin decoction on rats with ulcerative colitis of damp-heat type base on mtDNA, TLR4, p-PI3K, p-akt protein expression and microbiota. J Ethnopharmacol 295:115356","journal-title":"J Ethnopharmacol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05680-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05680-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05680-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:01:49Z","timestamp":1792886509000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05680-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":45,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["5680"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05680-4","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"29 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}